Explore more publications!

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on March 2, 2026

Living with a Rare Disease: A Pastor’s Journey Finding the Right Care and Treatment for NF1-PN 
Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform
Don’t Kidney Around This National Kidney Month, Get the Facts Your Kidneys Wish You Knew
Academy of Nutrition and Dietetics Celebrates Power of Nutrition for 2026 National Nutrition Month®
Health-ISAC Releases Its 2025 Annual Report
Why some teens feel less happy: Sleep and mindfulness may hold the key
Interra Health, created through the merger of DoseSpot and Arrive Health, ushers in a new era of transparency for patients and providers
SAB BIO to Participate in Upcoming Investor Conferences
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
Palisade Bio Announces Participation in Two Upcoming Investor Conferences
Award-Winning Speaker Mike Veny Launches “Coffee with Mike” Mental Health Podcast for Workplace Leaders
MyFitnessPal Acquires Cal AI, Expanding on its Position as the Leading Player in Digital Nutrition Tracking
Oncolytics Biotech® Launches Randomized Colorectal Cancer Study
Ascendis Pharma to Participate in the TD Cowen 46th Annual Health Care Conference
Allogene Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Imviva Biotech Announces Acceptance of Late-Breaking Abstract Highlighting Data from Ongoing Phase 1/2 Study of CTA313 at 15th European Lupus Meeting
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions